Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Arylacenamide in non-metastatic androgen-independent prostate cancer
NCT00174863Phase 2Completed
- Sponsor
- Sanofi
- Start
- Oct 2003
- Primary completion
- Aug 2006
- Modality
- Small Molecules
- Countries
- 13
01
Overview
A Phase 2 trial of RU 58642 in prostate cancer (PCa), sponsored by Sanofi. Started Oct 2003; status: completed.
02
Drugs
RU 58642
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00174863.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00174863.